These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6441608)

  • 21. In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities.
    Löscher W; Vetter M
    Biochem Pharmacol; 1985 May; 34(10):1747-56. PubMed ID: 3924047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous gamma-hydroxybutyrate in rat brain areas: postmortem changes and effects of drugs interfering with gamma-aminobutyric acid metabolism.
    Eli M; Cattabeni F
    J Neurochem; 1983 Aug; 41(2):524-30. PubMed ID: 6875551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproate increases diazepam impregnation selectively in CNS of the rat after subchronic administration.
    Hariton C; Jadot G; Mesdjian E; Cano JP; Mandel P
    Life Sci; 1985 Oct; 37(14):1343-9. PubMed ID: 3930906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproate metabolites in the rat brain--regional distribution in various brain areas.
    Darius J; Meyer FP; Bergsträsser E; Ebermann E; Andreas K
    Eur J Drug Metab Pharmacokinet; 1999; 24(1):97-104. PubMed ID: 10412898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved method for isolating synaptosomes from 11 regions of one rat brain: electron microscopic and biochemical characterization and use in the study of drug effects on nerve terminal gamma-aminobutyric acid in vivo.
    Löscher W; Böhme G; Müller F; Pagliusi S
    J Neurochem; 1985 Sep; 45(3):879-89. PubMed ID: 3928810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of milacemide, a glycinamide derivative, on the rat brain gamma-aminobutyric acid system.
    de Varebeke PJ; Niebes P; Pauwels G; Roba J; Korf J
    Biochem Pharmacol; 1983 Sep; 32(18):2751-5. PubMed ID: 6414480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action.
    Löscher W
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):32-58. PubMed ID: 6810779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of valproic acid in cultured mammalian neurons.
    Buchhalter JR; Dichter MA
    Neurology; 1986 Feb; 36(2):259-62. PubMed ID: 3003620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of sodium valproate in dog and mouse.
    Löscher W; Esenwein H
    Arzneimittelforschung; 1978; 28(5):782-7. PubMed ID: 373773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of sodium valproate and gamma-vinyl GABA on regional amino acid metabolism in the rat brain: incorporation of 2-[14C]glucose into amino acids.
    Chapman AG; Riley K; Evans MC; Meldrum BS
    Neurochem Res; 1982 Sep; 7(9):1089-105. PubMed ID: 6817155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the biological activity of sodium valproate and L-lysine valproate on brain GABA levels by (3H) muscimol radioreceptor assay.
    Brunet C; Luyckx M; Bianchi A; Paluszezak D
    Farmaco Prat; 1988 Sep; 43(9):291-6. PubMed ID: 3149246
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings.
    Löscher W; Böhme G; Schäfer H; Kochen W
    Neuropharmacology; 1981 Dec; 20(12A):1187-92. PubMed ID: 6798485
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of arrhythmias and cardiac fibrillation in acute ischemia and reperfusion by using a factor causing GABA accumulation in the brain].
    Meerson FZ; Shabunina EV; Belkina LM; Pshennikova MG
    Kardiologiia; 1987 May; 27(5):87-9. PubMed ID: 3116316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L
    Acta Neurol Scand; 1988 Oct; 78(4):241-70. PubMed ID: 3146860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [
    Bertelsen F; Landau AM; Vase KH; Jacobsen J; Scheel-Krüger J; Møller A
    Brain Res; 2018 Feb; 1680():110-114. PubMed ID: 29258847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute stress and GABAergic function in the rat brain.
    Otero Losada ME
    Br J Pharmacol; 1989 Mar; 96(3):507-12. PubMed ID: 2720289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of neonatal brain fuel utilization by valproate and E-delta 2-valproate is not a consequence of the stimulation of the gamma-aminobutyric acid shunt.
    Bolaños JP; Medina JM
    Life Sci; 1994; 55(20):PL397-402. PubMed ID: 7968221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of some anticonvulsant drugs on brain GABA level and GAD and GABA-T activities.
    Battistin L; Varotto M; Berlese G; Roman G
    Neurochem Res; 1984 Feb; 9(2):225-31. PubMed ID: 6429560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.
    Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.